Cargando…
Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours
Coactivating and inhibitory receptors that share at least one ligand interact with a wide variety of ligands, indicating their importance in a range of situations. Here, we discuss principles of mainly human paired receptor function and ligand recognition, and possible therapeutic implications of ta...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106362/ https://www.ncbi.nlm.nih.gov/pubmed/29066058 http://dx.doi.org/10.1016/j.it.2017.10.001 |
_version_ | 1783512595733413888 |
---|---|
author | Levi-Schaffer, Francesca Mandelboim, Ofer |
author_facet | Levi-Schaffer, Francesca Mandelboim, Ofer |
author_sort | Levi-Schaffer, Francesca |
collection | PubMed |
description | Coactivating and inhibitory receptors that share at least one ligand interact with a wide variety of ligands, indicating their importance in a range of situations. Here, we discuss principles of mainly human paired receptor function and ligand recognition, and possible therapeutic implications of targeting these receptors in cancer, autoimmune diseases, and allergy. We summarise and emphasise the idea that these receptors, which have evolved in part in response to pathogen pressure, fine-tune the immune response, preserve homeostasis, and that pathogens and tumours use the dominance of the inhibitory receptors over the coactivating receptors to avoid immune elimination. Finally, we discuss the options of using paired receptors and their ligand for immune cell education and therapy. |
format | Online Article Text |
id | pubmed-7106362 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71063622020-03-31 Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours Levi-Schaffer, Francesca Mandelboim, Ofer Trends Immunol Review Coactivating and inhibitory receptors that share at least one ligand interact with a wide variety of ligands, indicating their importance in a range of situations. Here, we discuss principles of mainly human paired receptor function and ligand recognition, and possible therapeutic implications of targeting these receptors in cancer, autoimmune diseases, and allergy. We summarise and emphasise the idea that these receptors, which have evolved in part in response to pathogen pressure, fine-tune the immune response, preserve homeostasis, and that pathogens and tumours use the dominance of the inhibitory receptors over the coactivating receptors to avoid immune elimination. Finally, we discuss the options of using paired receptors and their ligand for immune cell education and therapy. Elsevier Ltd. 2018-02 2017-10-20 /pmc/articles/PMC7106362/ /pubmed/29066058 http://dx.doi.org/10.1016/j.it.2017.10.001 Text en © 2017 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Levi-Schaffer, Francesca Mandelboim, Ofer Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
title | Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
title_full | Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
title_fullStr | Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
title_full_unstemmed | Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
title_short | Inhibitory and Coactivating Receptors Recognising the Same Ligand: Immune Homeostasis Exploited by Pathogens and Tumours |
title_sort | inhibitory and coactivating receptors recognising the same ligand: immune homeostasis exploited by pathogens and tumours |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7106362/ https://www.ncbi.nlm.nih.gov/pubmed/29066058 http://dx.doi.org/10.1016/j.it.2017.10.001 |
work_keys_str_mv | AT levischafferfrancesca inhibitoryandcoactivatingreceptorsrecognisingthesameligandimmunehomeostasisexploitedbypathogensandtumours AT mandelboimofer inhibitoryandcoactivatingreceptorsrecognisingthesameligandimmunehomeostasisexploitedbypathogensandtumours |